Stay updated on Investigational Drug in Acutely Psychotic Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Investigational Drug in Acutely Psychotic Schizophrenia Clinical Trial page.

Latest updates to the Investigational Drug in Acutely Psychotic Schizophrenia Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new revision entry (Revision: v3.4.2) to the history, and removed older notices about funding and operating status.SummaryDifference0.5%

- Check41 days agoChange DetectedA general funding/status notice was added and the site revision was updated from v3.4.0 to v3.4.1. Core study record content and history listings appear unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedThe Record History page now shows a glossary option and color-coded change highlights (green for additions and red for deletions). Footer text updates include 'No FEAR Act Data' and a new Revision: v3.4.0, replacing the previous revision label, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check62 days agoChange DetectedThe history shows a new revision label v3.3.4 and removal of v3.3.3, reflecting an administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now displays a new 'Revision: v3.3.3' label, and the previous 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items are removed from the footer.SummaryDifference0.1%

Stay in the know with updates to Investigational Drug in Acutely Psychotic Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Investigational Drug in Acutely Psychotic Schizophrenia Clinical Trial page.